Navigation Links
Gauging Brain Cancer Survival Time May Get Easier: Study
Date:4/10/2013

WEDNESDAY, April 10 (HealthDay News) -- Life expectancy of people with aggressive brain cancer may be easier to determine with a new method under development at the University of Alabama at Birmingham, researchers say.

The UAB researchers found that patients with an overactive version of a specific enzyme live less than half as long as those with a less active version. This overactive enzyme can help predict how resistant the brain cancer will be to chemotherapy, and also help doctors arrive at treatment recommendations, the researchers said.

In conducting the study, published April 10 in the journal PLoS ONE, the researchers examined tumors from 84 patients with a form of brain cancer known as glioblastoma multiforme (GBM). This deadly and aggressive cancer quickly becomes resistant to available treatments. With a combination of surgery, radiation and the chemotherapy drug temozolomide, patients with this form of brain cancer typically survive an average of 12 to 15 months.

The study revealed, however, that 25 percent to 30 percent of the patients whose tumor cells had an overactive version of an enzyme known as cytochrome c oxidase (CcO) live less than half as long as patients with a less active version.

"Our study reports for the first time the role of [CcO] as a prognostic marker in GBM patients' tumor tissues," study leader Corinne Griguer, an associate professor of neurosurgery in the UAB School of Medicine, said in a university news release. "High CcO activity comes with a 25-fold increase in risk of death."

The researchers said patients with the overactive enzyme lived for an average of six months. Those with a less active version lived for 14 months. Examination of a second group of glioblastoma multiforme patients from Europe confirmed their findings, the researchers said.

They concluded that tumor cells with increased CcO activity generate more energy and are more resistant to chemotherapy. The overactive enzyme also interferes with a protein, called cytochrome c, that triggers the self-destruction of cells infected or damaged by diseases such as cancer. When this happens, cancer cells can survive an abnormally long time.

But the researchers aren't stopping with this finding. "Giving some GBM patients bad news about their prognoses without also giving them better treatment options doesn't seem right to me," said Griguer, noting that the team is experimenting with another enzyme to try to predict patients' survival benefit from the chemo drug temozolomide.

"Our ultimate goal is to use the same mechanism that predicts shorter survival in some to design drugs that target cells not killed right away by chemotherapy," she said.

More information

The U.S. National Institutes of Health provides more information on brain cancer.

-- Mary Elizabeth Dallas

SOURCE: University of Alabama at Birmingham, news release, April 10, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Gauging seizures severity
2. For First Time, Pain Signature Spotted on Brain MRIs
3. Brain Surgery Eases Compulsive Eating in 10-Year-Old Girl
4. A New Peer-Reviewed Study Using CogniFit Brain Training Provides A Breakthrough In The Treatment Of Insomnia
5. RI Hospital: Traumatic brain injury worsens outcomes for those with nonepileptic seizures
6. Extracellular vesicles may open new opportunities for brain cancer diagnosis and treatment
7. Non-invasive mapping helps to localize language centers before brain surgery
8. Scans May Reveal Pre-Schizophrenia Brain Changes
9. Sexuality, traumatic brain injury, and rehabilitation
10. New minimally invasive, MRI-guided laser treatment for brain tumor found to be promising in study
11. Voices Against Brain Cancer Responds to Research Identifying Contributing Factor in Brain Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gauging Brain Cancer Survival Time May Get Easier: Study
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: